Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Grants (Details)

v3.24.3
Stock-Based Compensation - Grants (Details)
shares in Thousands
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Series A common stock  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at beginning of period | shares 23,530
Forfeited/Cancelled | shares (3,580)
Outstanding at end of period | shares 19,950
Exercisable at end of period | shares 17,755
WAEP  
Outstanding at beginning of period | $ / shares $ 7.72
Forfeited/Cancelled | $ / shares 10.24
Outstanding at end of period | $ / shares 7.27
Exercisable at end of period | $ / shares $ 7.11
Additional disclosures  
Weighted average remaining life - options outstanding 2 years
Weighted average remaining life - options exercisable 1 year 10 months 24 days
Series B common stock  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at beginning of period | shares 723
Forfeited/Cancelled | shares (316)
Outstanding at end of period | shares 407
Exercisable at end of period | shares 407
WAEP  
Outstanding at beginning of period | $ / shares $ 12.35
Forfeited/Cancelled | $ / shares 11.59
Outstanding at end of period | $ / shares 12.95
Exercisable at end of period | $ / shares $ 12.95
Additional disclosures  
Weighted average remaining life - options outstanding 6 months
Weighted average remaining life - options exercisable 6 months